A Phase 3, Long-Term, Randomized, Double-Blind, Placebo-Controlled trial of Troriluzole in Adult Subjects with Spinocerebellar Ataxia
Clinical Trial Grant
Administered By
Neurology, Movement Disorders
Awarded By
Biohaven Pharmaceuticals
Start Date
July 3, 2019
End Date
December 31, 2023
Administered By
Neurology, Movement Disorders
Awarded By
Biohaven Pharmaceuticals
Start Date
July 3, 2019
End Date
December 31, 2023